NH SPECIAL PURPOSE ACQTN 2ND CO LTD Inactive Instrument
NH Special Purpose Acqtn 2Nd Co Ltd Stock Korea S.E.
Equities
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
||
| - | - |
|
| Sales 2024 * | 149B 108M 0 | Sales 2025 * | 183B 133M 0 | Capitalization | 333B 242M 0 |
|---|---|---|---|---|---|
| Net income 2024 * | 32B 23.2M - | Net income 2025 * | 39B 28.27M - | EV / Sales 2024 * | 1.75 x |
| Net cash position 2024 * | 73B 52.92M 0 | Net cash position 2025 * | 85B 61.62M 0 | EV / Sales 2025 * | 1.35 x |
| P/E ratio 2024 * |
11.3
x | P/E ratio 2025 * |
9.14
x | Employees | - |
| Yield 2024 * |
0.99% | Yield 2025 * |
0.99% | Free-Float | 59.1% |
More Fundamentals
* Assessed data
More news
| Managers | Title | Age | Since |
|---|---|---|---|
Ui-Yeol Choe
CEO | Chief Executive Officer | 63 | 97-12-31 |
Ki-Bong Nam
CTO | Chief Tech/Sci/R&D Officer | 68 | 08-12-31 |
Yong-Hwan Byeon
BRD | Director/Board Member | 69 | 15-07-27 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ui-Yeol Choe
CEO | Chief Executive Officer | 63 | 97-12-31 |
Kang-Oh Kim
BRD | Director/Board Member | 51 | 16-12-31 |
Ki-Bong Nam
CTO | Chief Tech/Sci/R&D Officer | 68 | 08-12-31 |
Boditech Med Inc is a Korea-based company principally engaged in the manufacture and sale of medical equipment. The Company is engaged in the manufacture and sale of antigen diagnostic kits and other products. In addition, the Company is engaged in the manufacture and sale of cancer diagnostic kit, drug concentration diagnostic kit and other products.
Calendar
2024-05-12
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -48.09% | 2.59B | |
| +4.82% | 1.61B | |
| -12.79% | 1.43B | |
| +22.29% | 1.22B | |
| -14.90% | 979M | |
| -23.61% | 880M | |
| -9.43% | 718M | |
| -17.46% | 687M | |
| +3.77% | 474M |
